NCT00150514View on ClinicalTrials.gov

Effects of Sublingual Immunotherapy on Grasspollen Allergy

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

December 31, 2006

Conditions
Hayfever
Interventions
DRUG

Oralgen

PROCEDURE

Nasal biopsy

PROCEDURE

Nasal washing

PROCEDURE

Peak nasal inspiratory flow

Trial Locations (1)

6500

Radboud university hospital, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT00150514 - Effects of Sublingual Immunotherapy on Grasspollen Allergy | Biotech Hunter | Biotech Hunter